Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ovalle, F.
Right arrow Articles by Cryer, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ovalle, F.
Right arrow Articles by Cryer, P. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 47, Issue 9 1472-1479, Copyright © 1998 by American Diabetes Association


ARTICLES

Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus

F Ovalle, CG Fanelli, DS Paramore, T Hershey, S Craft and PE Cryer
Division of Endocrinology, Diabetes, and Metabolism, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

We tested the hypothesis that as few as two weekly brief episodes of superimposed hypoglycemia (i.e., doubling the average frequency of symptomatic hypoglycemia) would reduce physiological and behavioral defenses against developing hypoglycemia and reduce detection of clinical hypoglycemia in patients with type 1 diabetes mellitus (T1DM). Compared with nondiabetic controls, six patients with well-controlled T1DM (HbA1c, 7.5 +/- 0.7% [mean +/- SD]) exhibited absent glucagon responses and reduced epinephrine (P = 0.0027), norepinephrine (P = 0.0007), pancreatic polypeptide (P = 0.0030), and neurogenic symptom (P = 0.0451) responses to hypoglycemia as expected. In these patients, 2 h of induced hypoglycemia (50 mg/dl, 2.8 mmol/l) twice weekly for 1 month, compared in a random-sequence crossover design with an otherwise identical 2 h of induced hyperglycemia (150 mg/dl, 8.3 mmol/l) twice weekly for 1 month, further reduced the epinephrine (P = 0.0001) and pancreatic polypeptide (P = 0.0030) responses, tended to further reduce the norepinephrine and neurogenic symptom responses to hypoglycemia, and reduced cognitive dysfunction during hypoglycemia (P = 0.0271), all assessed in the investigational setting. In the clinical setting, induced hypoglycemia did not alter overall glycemic control, but did reduce the total number of symptomatic hypoglycemic episodes detected by the patients from 49 to 30 per month and lowered the mean +/- SE self-monitored blood glucose level during symptomatic hypoglycemia from 51 +/- 2 mg/dl (2.8 +/- 0.1 mmol/l) to 46 +/- 3 mg/dl (2.6 +/- 0.2 mmol/l) (P < 0.01). It also reduced the proportion of low regularly scheduled self-monitored values that were symptomatic by approximately 33%. Thus as little as doubling the frequency of symptomatic hypoglycemia further reduced both the key epinephrine response and clinical awareness of developing hypoglycemia, changes reasonably expected to increase the risk of severe iatrogenic hypoglycemia in T1DM.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
N. N. Zammitt, R. E. Warren, I. J. Deary, and B. M. Frier
Delayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes: Effect of Impaired Awareness of Hypoglycemia
Diabetes, March 1, 2008; 57(3): 732 - 736.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
N. C. Tkacs and H. J. Thompson
From bedside to bench and back again: research issues in animal models of human disease.
Biol Res Nurs, July 1, 2006; 8(1): 78 - 88.
[Abstract] [PDF]


Home page
EndocrinologyHome page
K. E. Inouye, J. T. Y. Yue, O. Chan, T. Kim, E. M. Akirav, E. Park, M. C. Riddell, E. Burdett, S. G. Matthews, and M. Vranic
Effects of Insulin Treatment without and with Recurrent Hypoglycemia on Hypoglycemic Counterregulation and Adrenal Catecholamine-Synthesizing Enzymes in Diabetic Rats
Endocrinology, April 1, 2006; 147(4): 1860 - 1870.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. E. Cryer
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Diabetes, December 1, 2005; 54(12): 3592 - 3601.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. E. Inouye, O. Chan, J. T. Y. Yue, S. G. Matthews, and M. Vranic
Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E422 - E429.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. E. Cryer
Diverse Causes of Hypoglycemia-Associated Autonomic Failure in Diabetes
N. Engl. J. Med., May 27, 2004; 350(22): 2272 - 2279.
[Full Text] [PDF]


Home page
DiabetesHome page
B. Raju, V. P. McGregor, and P. E. Cryer
Cortisol Elevations Comparable to Those That Occur During Hypoglycemia Do Not Cause Hypoglycemia-Associated Autonomic Failure
Diabetes, August 1, 2003; 52(8): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. E. Cryer, S. N. Davis, and H. Shamoon
Hypoglycemia in Diabetes
Diabetes Care, June 1, 2003; 26(6): 1902 - 1912.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Schultes, K. M. Oltmanns, W. Kern, H. L. Fehm, J. Born, and A. Peters
Modulation of Hunger by Plasma Glucose and Metformin
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1133 - 1141.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. W. Paty, E. A. Ryan, A.M. J. Shapiro, J. R.T. Lakey, and R. P. Robertson
Intrahepatic Islet Transplantation in Type 1 Diabetic Patients Does Not Restore Hypoglycemic Hormonal Counterregulation or Symptom Recognition After Insulin Independence
Diabetes, December 1, 2002; 51(12): 3428 - 3434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Inouye, K. Shum, O. Chan, J. Mathoo, S. G. Matthews, and M. Vranic
Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats
Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1369 - E1379.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. M. Ryan, D. Dulay, C. Suprasongsin, and D. J. Becker
Detection of Symptoms by Adolescents and Young Adults With Type 1 Diabetes During Experimental Induction of Mild Hypoglycemia: Role of hormonal and psychological variables
Diabetes Care, May 1, 2002; 25(5): 852 - 858.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. P. McGregor, J. S. Greiwe, S. Banarer, and P. E. Cryer
Limited Impact of Vigorous Exercise on Defenses Against Hypoglycemia: Relevance to Hypoglycemia-Associated Autonomic Failure
Diabetes, May 1, 2002; 51(5): 1485 - 1492.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Banarer, V. P. McGregor, and P. E. Cryer
Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response
Diabetes, April 1, 2002; 51(4): 958 - 965.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Segel, D. S. Paramore, and P. E. Cryer
Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes
Diabetes, March 1, 2002; 51(3): 724 - 733.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Sakurai, B. Yang, T. Takata, and K. Yokono
Synaptic Adaptation to Repeated Hypoglycemia Depends on the Utilization of Monocarboxylates in Guinea Pig Hippocampal Slices
Diabetes, February 1, 2002; 51(2): 430 - 438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Cryer
Hypoglycemia-associated autonomic failure in diabetes
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1115 - E1121.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. M. Sanders and S. Ritter
Acute 2DG-Induced Glucoprivation or Dexamethasone Abolishes 2DG-Induced Glucoregulatory Responses to Subsequent Glucoprivation
Diabetes, December 1, 2001; 50(12): 2831 - 2836.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Segel, C. G. Fanelli, C. S. Dence, J. Markham, T. O. Videen, D. S. Paramore, W. J. Powers, and P. E. Cryer
Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia
Diabetes, August 1, 2001; 50(8): 1911 - 1917.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. P. McGregor, S. Banarer, and P. E. Cryer
Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E770 - E777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.